Evaluation of anti‑diabetic activity of methanolic extract from the bark of Atalantia monophylla (Linn.) in alloxan‑induced diabetic mice

Radhakrishnan Mahesh, Ankur Jindal, Baldev Gautam, Shvetank Bhatt, Dilip Pandey

Abstract


Objective: The objective of the present study was to evaluate the anti-diabetic activity of methanolic extract from the bark of
Atalantia monophylla (Linn.) in alloxan-induced diabetic mice. Materials and Methods: Diabetes was induced in mice by injection
of alloxan (200 mg/kg, i.p.). Diabetic mice were divided into different groups and methanolic bark extract of Atalantia monophylla (AMMt) was administered at dose ranges of 50–200 mg/kg, p.o for 14 days. Control group received normal saline (0.9%) for 14 days. Glibenclamide (4 mg/kg, p.o) was used as standard drug. Blood samples were collected from all the groups and analysed for serum glucose and lipid levels such as total cholesterol (TC), triglyceride (TG), high-density lipoprotein (HDL), low-density lipoprotein (LDL) and very low-density lipoprotein (VLDL). AMMt was also tested for oral glucose tolerance test (OGTT) in normal fasted rats. Results: AMMt (100 and 200 mg/kg, p.o) showed a significant (P<0.05) reduction of serum glucose level in alloxan-induced diabetic mice as compared with diabetic control. AMMt (100 and 200 mg/kg) also showed a significant reduction in serum TC, TG, LDL and VLDL levels in alloxan-induced diabetic mice. In addition, AMMt (100 and 200 mg/kg, p.o) significantly increased serum HDL level as compared with diabetic mice. AMMt (100 and 200 mg/kg, p.o) significantly (P<0.05) increased the glucose tolerance in OGTT. Conclusion: The results obtained from the present study revealed the potential anti-diabetic activity of methanolic extract
from the bark of A. monophylla.
Key words: Alloxan, anti‑diabetic, anti‑hyperlipidaemic, Atalantia monophylla

Full Text:

PDF

References


Clark TA, Pierce GN. Cardiovascular complications of

non‑insulin‑dependent diabetes: the JCR: LA‑cp rat. J Pharmacol

Toxicol Methods 2000;43:1‑10.

Taylor SI. Deconstructing type 2 diabetes. Cell 1999;97:9‑12.

King H, Aubert RE, Herman WH. Global burden of diabetes

–2025: prevalence, numerical estimates, and projections.

Diabetes Care 1998;21:1414‑31.

Kameswara Rao B, Renuka Sudarshan P, Rajasekhar MD,

Nagaraju N, Appa Rao Ch. Antidiabetic activity of Terminalia

pallida fruit in alloxan induced diabetic rats. J Ethnopharmacol

;85:169‑72.

Xie JT, Aung HH, Wu JA, Attele AS, Yuan CS. Effects of American

ginseng berry extract on blood glucose levels in ob/ob mice. Am

J Chin Med 2002;30:187‑94.

Panda H. Handbook on medicinal herbs with uses. Delhi: Asia

Pacific Business Press Inc.; 2004. p. 166‑7.

Basa SC. Atalaphyllinine, a new acridone base from Atalantia

monophylla. Phytochemistry 1975;14:835‑6.

Prasad YR. Chemical investigation and antimicrobial efficacy of the

volatile leaf oil of Atalantia monophylla Corr. Prafuemeria Kosmetic

;69:418‑9.

Pandey DK, Gupta S, Kurdekar V, Gautam B, Bhatt S,

Balasubramaniam A, et al. Studies on the anti‑oxidant, analgesic

and anti‑inflammatory properties of bark extract of Atalantia

Monophylla. Ethnopharmacol 2010;1:1‑5.

Garg MC, Bansal DD. Protective antioxidant effect of vitamins C

and E in streptozotocin induced diabetic rats. Indian J Exp Biol

;38:101‑14.

Kinoshita T, Hiraga Y, Nakamura N, Kitajo A, Iinuma F.

Determination of glucose in blood using glucose oxidase‑peroxidase

system and 8‑hydroxyquinline‑p‑anisidine. Chem Pharm Bull

(Tokyo) 1969;27:568‑70.

Li F, Zhang Y, Zhong Z. Antihyperglycemic effect of ganoderma

lucidum polysaccharides on streptozotocin‑induced diabetic mice.

Int J Mol Sci 2011;12:6135‑45.

Allain CC, Poon LS, Chan CS, Richmond W, Fu PC. Enzymatic

determination of total serum cholesterol. Clin Chem 1974;20:470‑5.

Werner M, Gabrielson DG, Eastman J. Ultramicro determination

of serum triglycerides by bioluminescent assay. Clin Chem

;27:268‑71.

Friedewald WT, Levy RI, Fredrickson DS. Estimation of the

concentration of low‑density lipoprotein cholesterol in plasma,

without use of the preparative ultracentrifuge. Clin Chem

;18:499‑502.

Zhang X, Liang W, Mao Y, Li H, Yang Y, Tan H. Hepatic glucokinase

activity is the primary defect in alloxan‑induced diabetes of mice.

Biomed Pharmacother 2009;63:180‑6.

Grover JK, Vats V, Rathi SS. Anti‑hyperglycemic effects of Eugenia

jambolana and Tinospora cardiofolia in experimental diabetes and

their effects on key enzymes involved in carbohydrate metabolism.

J Ethnopharmacol 2000;73:461‑70.

Kasiviswanath R, Ramesh A, Kumar KE. Hypoglycemic and

anithyperglycemic effect of Gmelina asaistica Linn. in normal and

in alloxan induced diabetic rats. Biol Pharm Bull 2005;28:729‑32.

Shukla R, Anand K, Prabhu KM, Murthy PS. Hypolipidemic effect

of water extract of Ficus bengalensis in alloxoan‑induced diabetes

mellitusin rabbits. Indian J Clin Biochem 1995;10:119‑21.

Joy KL, Kuttan R. Anti‑diabetic activity of Picrorrhiza kurroa

extract. J Ethnopharmacol 1999;67:143‑8.

Reddy SV, Tiwari AK, Kumar US, Rao RJ, Rao JM. Free radical

scavenging, enzyme inhibitory constituents from antidiabetic

Ayurvedic medicinal plant Hydnocarpus wightiana Blume.

Phytother Res 2005;19:277‑81.

Heikkila Re, Winstonm B, Cohen G. Alloxan‑induced diabetesevidence

for hydroxyl radicals as a cytotoxic intermediate.

Biochem Pharmacol 1976;25:1085‑92.

Baynes JW, Thorpe SR. The role of oxidative stress in diabetic

complications. Curr Opin Endocrinol 1996;3:277‑84.

Szkudelski T. The mechanism of alloxan and streptozotocin action

in β‑cells of the rat pancreas. Physiol Res 2001;50:536‑46.

Ahmad M, Akhtar MS, Malik T, Gilani AH. Hypoglycemic action

of flavonoids fraction of Cuminum nigrum seeds. Phytother Res

;14:103‑6.

Sheng XQ, Huang KX, Xu HB. Influence of alloxan‑induced

diabetes and selenite treatment on blood glucose and glutathione

levels in mice. J Trace Elem Med Biol 2005;18:261‑7.




DOI: http://dx.doi.org/10.22377/ijgp.v6i2.249

Refbacks

  • There are currently no refbacks.